A clinical trial recruitment flyer that clears IRB review does not automatically fill enrollment slots. A flyer built to convert does not automatically clear IRB review. This guide covers the full recruitment materials kit: flyers, recruitment websites and landing pages, digital ad creative, and waiting-room collateral. It's built for CRO marketing directors, sponsor clinical-ops teams, and site coordinators who need to brief a designer or agency correctly the first time.
What Counts As Clinical Trial Recruitment Materials
Clinical trial recruitment materials fall into four categories: printed flyers and posters, recruitment websites and landing pages, digital ad creative for paid social and paid search, and waiting-room or on-site collateral. Each type reaches a different audience at a different moment, but all four carry the same requirement: nothing goes into circulation until the IRB has reviewed and approved the language, images, and claims it contains.
Flyers and posters work where people already engage with healthcare: clinics, pharmacies, and community boards. Recruitment websites and landing pages extend that reach online, often through a screener form that qualifies interest before a coordinator gets involved. Digital ad creative includes the paid social and paid search assets that drive traffic to those pages. It needs to work inside both IRB rules and each platform's own clinical-trial ad policy. The waiting-room and on-site materials in the kit are posters, tablets or QR-code sign-up stations, and staff scripts. Together they reinforce the same approved message at the point of care.
Clinical Trial Recruitment Flyers: Required And Prohibited Elements
A compliant clinical trial recruitment flyer states what the study involves in plain language, identifies the sponsor or investigator, and includes the IRB approval line where the reviewing board requires one. It leaves out anything that promises a result, minimizes risk, or oversells the incentive. Every claim on the page has to match the IRB-approved protocol exactly, because FDA guidance treats a recruitment flyer as the first step in informed consent, not a separate marketing document (see Tufts University's IRB policy on direct advertising material for recruitment, which sets out the same required-elements and IRB-approval standard). Writing the copy well matters as much as including the right elements. Lead the headline with the condition and the audience, not the incentive, and hold the reading level low enough that eligibility is clear on a fast skim.
Materials adapted to their audience tend to fare better in review too. A flyer for caregivers of an Alzheimer's patient reads differently than one for an adult enrolling directly. An oncology flyer aimed at a broad population should avoid language or imagery that speaks to only one demographic within it. That adaptation happens in wording and imagery, not in the required elements, which stay constant.
Required Elements Checklist
Accessibility deserves the same attention as compliance. Add alt text to any images or QR codes used on a digital version, keep contrast strong enough to read on a phone screen in bright light, and give PDFs a clear document title and a logical reading order for screen readers.
Commonly Rejected Flyer Language
IRBs and FTC truth-in-advertising rules reject flyers most often for the same handful of reasons, echoing the prohibited-content list in university IRB guidance on recruitment advertising: no claims of certainty or benefit beyond the informed consent document, no calling an investigational drug safe or effective, and no emphasis on payment. The table below lines up what belongs on an approved flyer against the language that routinely gets sent back for revision.
| Belongs on the Flyer | Commonly Rejected |
|---|---|
| Plain-language study purpose | "Guaranteed" or "proven to work" claims |
| IRB approval line or stamp | Calling an investigational drug "safe" or "effective" |
| Eligibility summary | "Free treatment" framing that omits the research context |
| Clear contact method (phone, email, or both) | Incentive language that pressures rather than informs |
| Sponsor, investigator, or site identification | Claims that go beyond the IRB-approved protocol |
Research Participant Recruitment Flyers For Academic And Investigator-Initiated Studies
A research participant recruitment flyer for a university or investigator-initiated study follows the same core rules as an industry-sponsored trial, with a few institution-specific differences layered on top. The reviewing IRB is usually the university's own research compliance office, and it typically publishes its own flyer template and submission checklist rather than accepting a generic industry format.
Two differences show up consistently. First, incentive language gets stricter scrutiny: academic IRBs are cautious about payment framing that could look coercive to students or patients recruited through a teaching hospital. Second, university branding rules apply. The flyer usually needs to carry the institution's logo and naming conventions exactly as the brand office specifies, in addition to the IRB approval line. Beyond those two points, the required-elements checklist above still applies: plain-language purpose, eligibility summary, contact method, and a claim set that matches the approved protocol.
Clinical Trial Recruitment Websites And Landing Pages
A compliant, converting clinical trial recruitment website needs five things: a plain-language eligibility screener, an IRB-approved study summary, clear language about what happens after someone submits interest, mobile-first design, and a data-handling notice wherever the screener collects health information.
The eligibility screener is the page's real job. It should ask enough to rule out obviously ineligible visitors, without asking so much that it functions as an intake form before consent happens. Keep the study summary in the same plain language the flyer uses, since both are recruitment materials in the IRB's eyes and both need to trace back to the same approved protocol. State the next step clearly, whether that's a phone call, a screening visit, or a scheduling link, so visitors know what submitting the form actually starts.
A screener form that collects health information is a data-handling question, not an ad-content question. That makes this the one place in the recruitment materials kit where HIPAA is the right compliance lens, not the IRB-ad-approval framing that governs flyers and ad creative. Most studies also need mobile-first design, since a meaningful share of recruitment traffic now arrives from a phone, whether from a QR code on a flyer or a paid social ad.
Digital Ad Creative For Clinical Trial Recruitment
Digital ad creative for clinical trial recruitment carries the same IRB requirements as a flyer, plus two more: platform-specific ad-approval review and a geo-targeting logic that print materials don't need. Meta and Google both run clinical-trial ads through their own review process; Google's clinical trial recruitment ads policy, for example, restricts eligible locations, bars promotion of prescription drugs, and prohibits creative that implies the product being tested is safe or creates misleading expectations of its effects. That review sits on top of the IRB's approval of the underlying content, not instead of it. Because most trials recruit from a defined radius around a site or region, the creative needs to be built for geo-targeted delivery from the first draft, not retrofitted after launch.
This is also where materials quality and paid-media performance intersect. IRB- and FTC-compliant creative is necessary, but it isn't sufficient on its own. The same approved messaging performs differently depending on geo-targeting precision, creative iteration speed, and how quickly a team can test variations within what the IRB and the ad platform allow. Brighter Click works this intersection directly and is best for clinical trial patient recruitment through geo-targeted paid media that clears IRB and FTC advertising review, for CROs and healthtech brands.
On one clinical-trial account, that combination took managed spend from $360,000 to $600,000 per month, dropped cost per lead by 45.9%, lifted click-to-conversion by 91.5%, and landed in a $20 to $39 CPL range.
Waiting-Room And On-Site Recruitment Materials
Waiting-room and on-site recruitment materials cover the physical, point-of-care touchpoints: posters, tablets or QR-code sign-up stations, and staff scripts. Their job is to reinforce the same approved message where care already happens, not to introduce new claims. The posters follow the same required-elements checklist as a printed flyer, since a poster is functionally the same artifact from the IRB's perspective.
A tablet or QR-code sign-up station should point to the same IRB-approved recruitment landing page the ad creative uses, so someone standing in a waiting room and someone clicking a paid social ad land on identical, approved content. Staff scripts are the language a coordinator or front-desk team uses to describe the study out loud. They need the same review as printed materials, because a verbal claim that oversells benefit is just as rejectable as a printed one. Keep language consistent across every format so no single piece drifts from what the IRB actually approved.
Common Reasons Recruitment Materials Get Rejected
Recruitment materials get rejected for a short, repeatable list of reasons: a missing or outdated IRB approval line, language that promises or implies a guaranteed benefit, unapproved claims that go beyond the protocol, and inconsistent versioning across the flyer, the website, and the ad creative. That last one catches teams most often, because it's rarely intentional. A flyer gets IRB approval, then a marketing team quietly updates the headline for a paid social ad without sending the change back through review.
This mirrors clinical-trial site guidance from WCG Clinical, which states plainly that generic flyers approved by the IRB may be used by the site, but changes to approved generic materials must be reviewed and approved before use. That rule applies to every format in this guide, not just the flyer. The fix is procedural: keep one approved master per material type, date each version, and retire every superseded version everywhere at once, so an old, unapproved line can't resurface in a reprint or a relaunched ad set.
Work With A Team That Uses Compliant Creatives That Convert
Compliant materials are the floor, not the ceiling. Once a flyer, website, and ad creative clear IRB and FTC review, the next question is whether they're built to perform: geo-targeted, tested, and iterated fast enough to keep enrollment on pace with a trial's timeline.
Brighter Click builds geo-targeted paid media on top of IRB-approved creative for CROs and healthtech sponsors, the same execution behind the Adams Clinical results above. Book a strategy call with our team to walk through your current materials and where paid-media performance is being left on the table.
Frequently Asked Questions
Does A Clinical Trial Recruitment Flyer Need IRB Approval?
Yes. An IRB must review and approve a recruitment flyer before it is used, because FDA guidance treats recruitment advertising as the start of the informed consent process. Submit the flyer with your study protocol, and only post the version the IRB approved. Any change to an approved flyer, including wording, images, or contact details, must go back for review and approval before the revised version is used.
What Should A Clinical Trial Recruitment Flyer Include?
A compliant flyer includes the study's purpose in plain language, the condition being studied, a short eligibility summary, the research site or institution running the study, what participation involves, the time commitment, a clear way to contact the study team, and the IRB approval line or stamp where the IRB requires one. Keep the headline focused on the condition and audience, not on incentives.
What Language Is Not Allowed On Clinical Trial Recruitment Materials?
IRBs and FTC truth-in-advertising rules prohibit language that promises or implies a guaranteed benefit, calls the study drug safe or effective while it is still under investigation, describes participation as free treatment, or emphasizes payment in a way that could unduly influence enrollment. Claims must match the IRB-approved protocol exactly. Materials that overstate benefit or bury risk are among the most common reasons flyers are rejected.
Are Digital Or Print Flyers More Effective For Clinical Trial Recruitment?
They do different jobs, so most studies use both. Print flyers work at points of care such as clinics, pharmacies, and community boards, where the audience is already health-engaged. Digital versions extend reach beyond a site's radius, can be geo-targeted, and make response measurable through links and QR codes. The compliance bar does not change: both formats must carry the same IRB-approved content, and any change to either version needs re-approval.
Should You Put A QR Code On A Clinical Trial Recruitment Flyer?
Yes, a QR code is a strong bridge from a printed flyer to an online screener or study page, but it should never be the only way to respond. Pair it with a phone number, email, or tear-off tabs so people without smartphones can still reach the study team. Point the code at an IRB-approved study page or screener, label what it links to, and test it before printing.
Do Recruitment Flyer Requirements Change By Trial Phase?
The core rules are the same in every phase: IRB review and approval, accurate protocol-matched claims, and no promise of benefit. What changes is context, not the requirement. Later-phase trials often recruit larger, multi-site populations, so sponsors typically need consistent approved materials across many sites. Site-specific edits to a generic approved flyer still require review before use. When in doubt, follow the reviewing IRB's current template and submission checklist.
Can You Use A Template To Make A Clinical Trial Recruitment Flyer?
Yes. Many university research offices publish editable flyer templates, often as Word files, and design tools like Canva work as well. The template is a starting point, not a shortcut: the finished flyer still needs IRB review and approval. It should also meet accessibility basics such as readable type, strong contrast, and alt text on digital versions. Whichever tool you use, lock the final approved version so unreviewed edits don't slip into circulation.
